IMRN Immuron Limited ADRs

Immuron Ltd is a biopharmaceutical company which develops polyclonal antibodies for the treatment and prevention of diseases. It products include Travelan, IMM-124E for NASH and IMM-529 for Clostridium difficile infection. This is an ADR of a company whose stock trades outside of the U.S. as the symbol AT:IMC.

$3.70  -0.01 (-0.27%)
As of 01/26/2022 14:54:32 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Australia
Country of incorporation:  Australia
IPO date:  06/09/2017
Outstanding shares:  5,694,959
Average volume:  2,893,392
Market cap:   $20,501,852
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.81
PS ratio:   8.93
Return on equity:   -17.71%
Net income %:   -142.74%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy